Emerson Q2 adjusted EPS rises 9% to $1.48; outlook raised, GAAP EPS falls to $0.86
Emerson reported fiscal second-quarter results for the quarter ended March 31, 2025, with net sales up 1% to $4.43 billion and adjusted EPS up 9% to $1.48. GAAP EPS fell 9% to $0.86, and pretax earnings declined to $629 million from $711 million, reflecting transaction-related costs tied to the AspenTech buy-in. The company raised its fiscal 2025 net sales growth guidance to about 4% and its adjusted EPS guidance at the midpoint, while lowering the GAAP EPS outlook to $4.05 to $4.20.
Key points
- Net sales rose to $4,432 million from $4,376 million; underlying sales grew 2% and underlying orders grew 4%.
- Adjusted EPS was $1.48 versus $1.36, while GAAP EPS was $0.86 versus $0.95, with acquisition and divestiture fees of $168 million in the quarter.
- Fiscal 2025 adjusted EPS guidance is $5.90 to $6.05; operating cash flow guidance is $3.5 billion to $3.6 billion and free cash flow guidance is $3.1 billion to $3.2 billion.
- The 2025 outlook assumes about $2.3 billion returned to shareholders, including $1.1 billion of share repurchases; the company completed the AspenTech buy-in on March 12, 2025.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.